Leonard C. Glass

Statistics

Publications

Citations

4.2K

H-Index

Active since

2001

Affiliations

The University of Texas at San Antonio Health Science Center(Current)

Eli Lilly (United States)

Texas Diabetes Institute

Istituto di Fisiologia Clinica

Park Nicollet Clinic

Leonard C. Glass is an author at The University of Texas at San Antonio Health Science Center specializing in endocrinology, diabetes mellitus, and diabetology.

Publications per year

2001–2025

Publications

The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes

Gregory Gaich, Jenny Y. Chien, Haoda Fu et al. · Cell Metabolism · 2013 · 879 citations · Full text

Medicine, Endocrinology, Pharmacology +11

Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes

John B. Buse, Richard M. Bergenstal, Leonard C. Glass et al. · Annals of Internal Medicine · 2011 · 506 citations

Medicine, Endocrinology, Pharmacology +17

Tirzepatide as Compared with Semaglutide for the Treatment of Obesity

Louis J. Aronne, Deborah B. Horn, Carel W. le Roux et al. · New England Journal of Medicine · 2025 · 418 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Improved Glycemic Control and Enhanced Insulin Sensitivity in Type 2 Diabetic Subjects Treated With Pioglitazone

Yoshinori Miyazaki, Archana Mahankali, Masafumi Matsuda et al. · Diabetes Care · 2001 · 406 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Decreased Plasma Adiponectin Concentrations Are Closely Related to Hepatic Fat Content and Hepatic Insulin Resistance in Pioglitazone-Treated Type 2 Diabetic Patients

Mandeep Bajaj, Swangjit Suraamornkul, Paul K. Piper et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 356 citations

Medicine, Endocrinology, Pharmacology +17

1–5 of 23